APO Research
Talk to an analyst

APO RESEARCH · REPORT

Phenylpropanolamine

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Phenylpropanolamine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

19 December 2025192 pages

Choose your research edition.

Industry ResearchPhenylpropanolamine Industry Research Report 2026130 pages · $2,950 USDIndustry Growth & TrendsGlobal Phenylpropanolamine Industry Growth and Trends Forecast to 2032110 pages · $3,450 USDMarket StructureGlobal Phenylpropanolamine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Phenylpropanolamine Market Outlook and Growth Opportunities 2026204 pages · $4,250 USDMarket Analysis & ForecastGlobal Phenylpropanolamine Market Analysis and Forecast 2026-2032208 pages · $4,950 USD

Market perspective

The global Phenylpropanolamine market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Phenylpropanolamine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Phenylpropanolamine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Phenylpropanolamine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Phenylpropanolamine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Phenylpropanolamine include Abbott, GlaxoSmithKline (GSK), Tempo Scan Pacific, Schazoo, Sanofi-Aventis, Roemmers, Riemser Pharma, Medlink and Meda, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Phenylpropanolamine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Phenylpropanolamine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Phenylpropanolamine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Phenylpropanolamine market size, projected growth trends, production technologies, key applications, and end-use industries.

Phenylpropanolamine Segment by Company

Abbott

GlaxoSmithKline (GSK)

Tempo Scan Pacific

Schazoo

Sanofi-Aventis

Roemmers

Riemser Pharma

Medlink

Meda

IBL Healthcare

Helicon

Gräub

Gracia Pharmindo

Eipico

Carinopharm

Asuncion

Armoxindo

Phenylpropanolamine Segment by Type

Capsule

Tablet

Syrup

Phenylpropanolamine Segment by Application

Human

Veterinary

Phenylpropanolamine Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Phenylpropanolamine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Phenylpropanolamine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Phenylpropanolamine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Phenylpropanolamine market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Phenylpropanolamine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Phenylpropanolamine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Phenylpropanolamine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Phenylpropanolamine Industry Trends Table 2. Phenylpropanolamine Industry Drivers Table 3. Phenylpropanolamine Industry Opportunities and Challenges Table 4. Phenylpropanolamine Industry Restraints Table 5. Global Phenylpropanolamine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Phenylpropanolamine Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Phenylpropanolamine Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Phenylpropanolamine Sales Market Share by Manufacturers Table 9. Global Phenylpropanolamine Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Phenylpropanolamine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Phenylpropanolamine Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Phenylpropanolamine Manufacturers, Product Type & Application Table 13. Global Phenylpropanolamine Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Phenylpropanolamine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Capsule Table 17. Major Manufacturers of Tablet Table 18. Major Manufacturers of Syrup Table 19. Global Phenylpropanolamine Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Phenylpropanolamine Sales by Type (2021-2026) & (K Units) Table 21. Global Phenylpropanolamine Sales by Type (2027-2032) & (K Units) Table 22. Global Phenylpropanolamine Sales Market Share by Type (2021-2026) Table 23. Global Phenylpropanolamine Sales Market Share by Type (2027-2032) Table 24. Global Phenylpropanolamine Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 25. Global Phenylpropanolamine Revenue by Type (2021-2026) & (K Units) Table 26. Global Phenylpropanolamine Revenue by Type (2027-2032) & (K Units) Table 27. Global Phenylpropanolamine Revenue Market Share by Type (2021-2026) Table 28. Global Phenylpropanolamine Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Human Table 30. Major Manufacturers of Veterinary Table 31. Global Phenylpropanolamine Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global Phenylpropanolamine Sales by Application (2021-2026) & (K Units) Table 33. Global Phenylpropanolamine Sales by Application (2027-2032) & (K Units) Table 34. Global Phenylpropanolamine Sales Market Share by Application (2021-2026) Table 35. Global Phenylpropanolamine Sales Market Share by Application (2027-2032) Table 36. Global Phenylpropanolamine Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global Phenylpropanolamine Revenue by Application (2021-2026) & (K Units) Table 38. Global Phenylpropanolamine Revenue by Application (2027-2032) & (K Units) Table 39. Global Phenylpropanolamine Revenue Market Share by Application (2021-2026) Table 40. Global Phenylpropanolamine Revenue Market Share by Application (2027-2032) Table 41. Global Phenylpropanolamine Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global Phenylpropanolamine Sales by Region (2021-2026) & (K Units) Table 43. Global Phenylpropanolamine Sales Market Share by Region (2021-2026) Table 44. Global Phenylpropanolamine Sales Forecasted by Region (2027-2032) & (K Units) Table 45. Global Phenylpropanolamine Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Phenylpropanolamine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 47. North America Phenylpropanolamine Sales by Country (2021-2026) & (K Units) Table 48. North America Phenylpropanolamine Sales by Country (2027-2032) & (K Units) Table 49. Europe Phenylpropanolamine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. Europe Phenylpropanolamine Sales by Country (2021-2026) & (K Units) Table 51. Europe Phenylpropanolamine Sales by Country (2027-2032) & (K Units) Table 52. Asia Pacific Phenylpropanolamine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Asia Pacific Phenylpropanolamine Sales by Country (2021-2026) & (K Units) Table 54. Asia Pacific Phenylpropanolamine Sales by Country (2027-2032) & (K Units) Table 55. South America, Middle East and Africa Phenylpropanolamine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. South America, Middle East and Africa Phenylpropanolamine Sales by Country (2021-2026) & (K Units) Table 57. South America, Middle East and Africa Phenylpropanolamine Sales by Country (2027-2032) & (K Units) Table 58. Global Phenylpropanolamine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Phenylpropanolamine Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Phenylpropanolamine Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Phenylpropanolamine Revenue Market Share by Region (2021-2026) Table 62. Global Phenylpropanolamine Revenue Market Share by Region (2027-2032) Table 63. Abbott Company Information Table 64. Abbott Business Overview Table 65. Abbott Phenylpropanolamine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Abbott Phenylpropanolamine Product Portfolio Table 67. Abbott Recent Development Table 68. GlaxoSmithKline (GSK) Company Information Table 69. GlaxoSmithKline (GSK) Business Overview Table 70. GlaxoSmithKline (GSK) Phenylpropanolamine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. GlaxoSmithKline (GSK) Phenylpropanolamine Product Portfolio Table 72. GlaxoSmithKline (GSK) Recent Development Table 73. Tempo Scan Pacific Company Information Table 74. Tempo Scan Pacific Business Overview Table 75. Tempo Scan Pacific Phenylpropanolamine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Tempo Scan Pacific Phenylpropanolamine Product Portfolio Table 77. Tempo Scan Pacific Recent Development Table 78. Schazoo Company Information Table 79. Schazoo Business Overview Table 80. Schazoo Phenylpropanolamine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Schazoo Phenylpropanolamine Product Portfolio Table 82. Schazoo Recent Development Table 83. Sanofi-Aventis Company Information Table 84. Sanofi-Aventis Business Overview Table 85. Sanofi-Aventis Phenylpropanolamine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Sanofi-Aventis Phenylpropanolamine Product Portfolio Table 87. Sanofi-Aventis Recent Development Table 88. Roemmers Company Information Table 89. Roemmers Business Overview Table 90. Roemmers Phenylpropanolamine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Roemmers Phenylpropanolamine Product Portfolio Table 92. Roemmers Recent Development Table 93. Riemser Pharma Company Information Table 94. Riemser Pharma Business Overview Table 95. Riemser Pharma Phenylpropanolamine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Riemser Pharma Phenylpropanolamine Product Portfolio Table 97. Riemser Pharma Recent Development Table 98. Medlink Company Information Table 99. Medlink Business Overview Table 100. Medlink Phenylpropanolamine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Medlink Phenylpropanolamine Product Portfolio Table 102. Medlink Recent Development Table 103. Meda Company Information Table 104. Meda Business Overview Table 105. Meda Phenylpropanolamine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Meda Phenylpropanolamine Product Portfolio Table 107. Meda Recent Development Table 108. IBL Healthcare Company Information Table 109. IBL Healthcare Business Overview Table 110. IBL Healthcare Phenylpropanolamine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. IBL Healthcare Phenylpropanolamine Product Portfolio Table 112. IBL Healthcare Recent Development Table 113. Helicon Company Information Table 114. Helicon Business Overview Table 115. Helicon Phenylpropanolamine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. Helicon Phenylpropanolamine Product Portfolio Table 117. Helicon Recent Development Table 118. Gräub Company Information Table 119. Gräub Business Overview Table 120. Gräub Phenylpropanolamine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. Gräub Phenylpropanolamine Product Portfolio Table 122. Gräub Recent Development Table 123. Gracia Pharmindo Company Information Table 124. Gracia Pharmindo Business Overview Table 125. Gracia Pharmindo Phenylpropanolamine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 126. Gracia Pharmindo Phenylpropanolamine Product Portfolio Table 127. Gracia Pharmindo Recent Development Table 128. Eipico Company Information Table 129. Eipico Business Overview Table 130. Eipico Phenylpropanolamine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 131. Eipico Phenylpropanolamine Product Portfolio Table 132. Eipico Recent Development Table 133. Carinopharm Company Information Table 134. Carinopharm Business Overview Table 135. Carinopharm Phenylpropanolamine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 136. Carinopharm Phenylpropanolamine Product Portfolio Table 137. Carinopharm Recent Development Table 138. Asuncion Company Information Table 139. Asuncion Business Overview Table 140. Asuncion Phenylpropanolamine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 141. Asuncion Phenylpropanolamine Product Portfolio Table 142. Asuncion Recent Development Table 143. Armoxindo Company Information Table 144. Armoxindo Business Overview Table 145. Armoxindo Phenylpropanolamine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 146. Armoxindo Phenylpropanolamine Product Portfolio Table 147. Armoxindo Recent Development Table 148. Key Raw Materials Table 149. Raw Materials Key Suppliers Table 150. Phenylpropanolamine Distributors List Table 151. Phenylpropanolamine Customers List Table 152. Research Programs/Design for This Report Table 153. Authors List of This Report Table 154. Secondary Sources Table 155. Primary Sources List of Figures Figure 1. Phenylpropanolamine Product Image Figure 2. Global Phenylpropanolamine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Phenylpropanolamine Market Size (2021-2032) & (US$ Million) Figure 4. Global Phenylpropanolamine Sales (2021-2032) & (K Units) Figure 5. Global Phenylpropanolamine Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Phenylpropanolamine Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Capsule Image Figure 9. Tablet Image Figure 10. Syrup Image Figure 11. Global Phenylpropanolamine Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Phenylpropanolamine Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Phenylpropanolamine Sales Market Share by Type (2021-2032) Figure 14. Global Phenylpropanolamine Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 15. Global Phenylpropanolamine Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Phenylpropanolamine Revenue Market Share by Type (2021-2032) Figure 17. Human Image Figure 18. Veterinary Image Figure 19. Global Phenylpropanolamine Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Phenylpropanolamine Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Phenylpropanolamine Sales Market Share by Application (2021-2032) Figure 22. Global Phenylpropanolamine Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Phenylpropanolamine Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Phenylpropanolamine Revenue Market Share by Application (2021-2032) Figure 25. North America Phenylpropanolamine Sales and Growth Rate (2021-2032) & (K Units) Figure 26. North America Phenylpropanolamine Sales Market Share by Country (2021-2032) Figure 27. U.S. Phenylpropanolamine Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Canada Phenylpropanolamine Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Mexico Phenylpropanolamine Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Phenylpropanolamine Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Phenylpropanolamine Sales Market Share by Country (2021-2032) Figure 32. Germany Phenylpropanolamine Sales and Growth Rate (2021-2032) & (K Units) Figure 33. France Phenylpropanolamine Sales and Growth Rate (2021-2032) & (K Units) Figure 34. U.K. Phenylpropanolamine Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Italy Phenylpropanolamine Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Netherlands Phenylpropanolamine Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Phenylpropanolamine Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Phenylpropanolamine Sales Market Share by Country (2021-2032) Figure 39. China Phenylpropanolamine Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Japan Phenylpropanolamine Sales and Growth Rate (2021-2032) & (K Units) Figure 41. South Korea Phenylpropanolamine Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Southeast Asia Phenylpropanolamine Sales and Growth Rate (2021-2032) & (K Units) Figure 43. India Phenylpropanolamine Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Australia Phenylpropanolamine Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Phenylpropanolamine Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Phenylpropanolamine Sales Market Share by Country (2021-2032) Figure 47. Brazil Phenylpropanolamine Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South Africa Phenylpropanolamine Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Saudi Arabia Phenylpropanolamine Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Turkey Phenylpropanolamine Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Argentina Phenylpropanolamine Sales and Growth Rate (2021-2032) & (K Units) Figure 52. UAE Phenylpropanolamine Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Egypt Phenylpropanolamine Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Chile Phenylpropanolamine Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Global Phenylpropanolamine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Phenylpropanolamine Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Phenylpropanolamine Revenue (2021-2032) & (US$ Million) Figure 58. North America Phenylpropanolamine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Phenylpropanolamine Revenue (2021-2032) & (US$ Million) Figure 60. Europe Phenylpropanolamine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Phenylpropanolamine Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Phenylpropanolamine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Phenylpropanolamine Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Phenylpropanolamine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Phenylpropanolamine Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Phenylpropanolamine Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Capsule
  • Tablet
  • Syrup
Applications
  • Human
  • Veterinary
Companies covered
  • Abbott
  • GlaxoSmithKline (GSK)
  • Tempo Scan Pacific
  • Schazoo
  • Sanofi-Aventis
  • Roemmers
  • Riemser Pharma
  • Medlink
  • Meda
  • IBL Healthcare
  • Helicon
  • Gräub
  • Gracia Pharmindo
  • Eipico
  • Carinopharm
  • Asuncion
  • Armoxindo

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Phenylpropanolamine Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Phenylpropanolamine Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Phenylpropanolamine Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Phenylpropanolamine Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Phenylpropanolamine Market Dynamics
  1. 2.1 Phenylpropanolamine Industry Trends
  2. 2.2 Phenylpropanolamine Industry Drivers
  3. 2.3 Phenylpropanolamine Industry Opportunities and Challenges
  4. 2.4 Phenylpropanolamine Industry Restraints
3 Phenylpropanolamine Market by Manufacturers
  1. 3.1 Global Phenylpropanolamine Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Phenylpropanolamine Sales by Manufacturers (2021-2026)
  3. 3.3 Global Phenylpropanolamine Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Phenylpropanolamine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Phenylpropanolamine Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Phenylpropanolamine Manufacturers, Product Type & Application
  7. 3.7 Global Phenylpropanolamine Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Phenylpropanolamine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Phenylpropanolamine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Phenylpropanolamine Tier 1, Tier 2, and Tier 3
4 Phenylpropanolamine Market by Type
  1. 4.1 Phenylpropanolamine Type Introduction
  2. 4.1.1 Capsule
  3. 4.1.2 Tablet
  4. 4.1.3 Syrup
  5. 4.2 Global Phenylpropanolamine Sales by Type
  6. 4.2.1 Global Phenylpropanolamine Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Phenylpropanolamine Sales by Type (2021-2032)
  8. 4.2.3 Global Phenylpropanolamine Sales Market Share by Type (2021-2032)
  9. 4.3 Global Phenylpropanolamine Revenue by Type
  10. 4.3.1 Global Phenylpropanolamine Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Phenylpropanolamine Revenue by Type (2021-2032)
  12. 4.3.3 Global Phenylpropanolamine Revenue Market Share by Type (2021-2032)
5 Phenylpropanolamine Market by Application
  1. 5.1 Phenylpropanolamine Application Introduction
  2. 5.1.1 Human
  3. 5.1.2 Veterinary
  4. 5.2 Global Phenylpropanolamine Sales by Application
  5. 5.2.1 Global Phenylpropanolamine Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Phenylpropanolamine Sales by Application (2021-2032)
  7. 5.2.3 Global Phenylpropanolamine Sales Market Share by Application (2021-2032)
  8. 5.3 Global Phenylpropanolamine Revenue by Application
  9. 5.3.1 Global Phenylpropanolamine Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Phenylpropanolamine Revenue by Application (2021-2032)
  11. 5.3.3 Global Phenylpropanolamine Revenue Market Share by Application (2021-2032)
6 Global Phenylpropanolamine Sales by Region
  1. 6.1 Global Phenylpropanolamine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Phenylpropanolamine Sales by Region (2021-2032)
  3. 6.2.1 Global Phenylpropanolamine Sales by Region (2021-2026)
  4. 6.2.2 Global Phenylpropanolamine Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Phenylpropanolamine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Phenylpropanolamine Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Phenylpropanolamine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Phenylpropanolamine Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Phenylpropanolamine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Phenylpropanolamine Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Phenylpropanolamine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Phenylpropanolamine Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Phenylpropanolamine Revenue by Region
  1. 7.1 Global Phenylpropanolamine Revenue by Region
  2. 7.1.1 Global Phenylpropanolamine Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Phenylpropanolamine Revenue by Region (2021-2026)
  4. 7.1.3 Global Phenylpropanolamine Revenue by Region (2027-2032)
  5. 7.1.4 Global Phenylpropanolamine Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Phenylpropanolamine Revenue (2021-2032)
  8. 7.2.2 North America Phenylpropanolamine Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Phenylpropanolamine Revenue (2021-2032)
  11. 7.3.2 Europe Phenylpropanolamine Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Phenylpropanolamine Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Phenylpropanolamine Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Phenylpropanolamine Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Phenylpropanolamine Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Abbott
  2. 8.1.1 Abbott Company Information
  3. 8.1.2 Abbott Business Overview
  4. 8.1.3 Abbott Phenylpropanolamine Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Abbott Phenylpropanolamine Product Portfolio
  6. 8.1.5 Abbott Recent Developments
  7. 8.2 GlaxoSmithKline (GSK)
  8. 8.2.1 GlaxoSmithKline (GSK) Company Information
  9. 8.2.2 GlaxoSmithKline (GSK) Business Overview
  10. 8.2.3 GlaxoSmithKline (GSK) Phenylpropanolamine Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 GlaxoSmithKline (GSK) Phenylpropanolamine Product Portfolio
  12. 8.2.5 GlaxoSmithKline (GSK) Recent Developments
  13. 8.3 Tempo Scan Pacific
  14. 8.3.1 Tempo Scan Pacific Company Information
  15. 8.3.2 Tempo Scan Pacific Business Overview
  16. 8.3.3 Tempo Scan Pacific Phenylpropanolamine Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Tempo Scan Pacific Phenylpropanolamine Product Portfolio
  18. 8.3.5 Tempo Scan Pacific Recent Developments
  19. 8.4 Schazoo
  20. 8.4.1 Schazoo Company Information
  21. 8.4.2 Schazoo Business Overview
  22. 8.4.3 Schazoo Phenylpropanolamine Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Schazoo Phenylpropanolamine Product Portfolio
  24. 8.4.5 Schazoo Recent Developments
  25. 8.5 Sanofi-Aventis
  26. 8.5.1 Sanofi-Aventis Company Information
  27. 8.5.2 Sanofi-Aventis Business Overview
  28. 8.5.3 Sanofi-Aventis Phenylpropanolamine Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Sanofi-Aventis Phenylpropanolamine Product Portfolio
  30. 8.5.5 Sanofi-Aventis Recent Developments
  31. 8.6 Roemmers
  32. 8.6.1 Roemmers Company Information
  33. 8.6.2 Roemmers Business Overview
  34. 8.6.3 Roemmers Phenylpropanolamine Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Roemmers Phenylpropanolamine Product Portfolio
  36. 8.6.5 Roemmers Recent Developments
  37. 8.7 Riemser Pharma
  38. 8.7.1 Riemser Pharma Company Information
  39. 8.7.2 Riemser Pharma Business Overview
  40. 8.7.3 Riemser Pharma Phenylpropanolamine Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Riemser Pharma Phenylpropanolamine Product Portfolio
  42. 8.7.5 Riemser Pharma Recent Developments
  43. 8.8 Medlink
  44. 8.8.1 Medlink Company Information
  45. 8.8.2 Medlink Business Overview
  46. 8.8.3 Medlink Phenylpropanolamine Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Medlink Phenylpropanolamine Product Portfolio
  48. 8.8.5 Medlink Recent Developments
  49. 8.9 Meda
  50. 8.9.1 Meda Company Information
  51. 8.9.2 Meda Business Overview
  52. 8.9.3 Meda Phenylpropanolamine Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Meda Phenylpropanolamine Product Portfolio
  54. 8.9.5 Meda Recent Developments
  55. 8.10 IBL Healthcare
  56. 8.10.1 IBL Healthcare Company Information
  57. 8.10.2 IBL Healthcare Business Overview
  58. 8.10.3 IBL Healthcare Phenylpropanolamine Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 IBL Healthcare Phenylpropanolamine Product Portfolio
  60. 8.10.5 IBL Healthcare Recent Developments
  61. 8.11 Helicon
  62. 8.11.1 Helicon Company Information
  63. 8.11.2 Helicon Business Overview
  64. 8.11.3 Helicon Phenylpropanolamine Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Helicon Phenylpropanolamine Product Portfolio
  66. 8.11.5 Helicon Recent Developments
  67. 8.12 Gräub
  68. 8.12.1 Gräub Company Information
  69. 8.12.2 Gräub Business Overview
  70. 8.12.3 Gräub Phenylpropanolamine Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Gräub Phenylpropanolamine Product Portfolio
  72. 8.12.5 Gräub Recent Developments
  73. 8.13 Gracia Pharmindo
  74. 8.13.1 Gracia Pharmindo Company Information
  75. 8.13.2 Gracia Pharmindo Business Overview
  76. 8.13.3 Gracia Pharmindo Phenylpropanolamine Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Gracia Pharmindo Phenylpropanolamine Product Portfolio
  78. 8.13.5 Gracia Pharmindo Recent Developments
  79. 8.14 Eipico
  80. 8.14.1 Eipico Company Information
  81. 8.14.2 Eipico Business Overview
  82. 8.14.3 Eipico Phenylpropanolamine Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Eipico Phenylpropanolamine Product Portfolio
  84. 8.14.5 Eipico Recent Developments
  85. 8.15 Carinopharm
  86. 8.15.1 Carinopharm Company Information
  87. 8.15.2 Carinopharm Business Overview
  88. 8.15.3 Carinopharm Phenylpropanolamine Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Carinopharm Phenylpropanolamine Product Portfolio
  90. 8.15.5 Carinopharm Recent Developments
  91. 8.16 Asuncion
  92. 8.16.1 Asuncion Company Information
  93. 8.16.2 Asuncion Business Overview
  94. 8.16.3 Asuncion Phenylpropanolamine Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Asuncion Phenylpropanolamine Product Portfolio
  96. 8.16.5 Asuncion Recent Developments
  97. 8.17 Armoxindo
  98. 8.17.1 Armoxindo Company Information
  99. 8.17.2 Armoxindo Business Overview
  100. 8.17.3 Armoxindo Phenylpropanolamine Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Armoxindo Phenylpropanolamine Product Portfolio
  102. 8.17.5 Armoxindo Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Phenylpropanolamine Value Chain Analysis
  2. 9.1.1 Phenylpropanolamine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Phenylpropanolamine Production Mode & Process
  6. 9.2 Phenylpropanolamine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Phenylpropanolamine Distributors
  9. 9.2.3 Phenylpropanolamine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst